Tau

There are 444 papers on Tau in aging research: 17 trials and 231 observational studies in people, 50 in animals, 2 in cells, 135 reviews. The newest story, Nov 12, 2026: “Spinal-fluid protein linked to Alzheimer’s progression”.

Biomarker

444 papers study it77 findings

17 new papers in 30 daysSee all 444 papers on Tau

At a glance

A human study links tau with Alzheimer's disease progression; human cohorts link it with worse cognition and, in people with elevated amyloid, worse everyday functioning. A human trial reports lower tau with a modified Mediterranean-ketogenic diet; a preprint trial reports no clear effect of low-dose rapamycin in APOE4 carriers or non-carriers.

77 findings in 67 papers from 2013 to 2026, 12 of them since April 2026

“Genetic correlation and polygenic overlap analyses indicate a common underlying genetic mechanism between the ALPS-index, ventricular volumes, and cerebrospinal fluid tau levels”
Genome-wide association study unravels mechanisms of brain glymphatic activityNature communications2025doi:10.1038/s41467-024-55706-9
  • Human trial17
  • Humans231
  • Animals50
  • Cells2
  • In silico6

Interventions

10

Rapamycin

no changein humans1downin rats1

2 studies
  1. Rapamycin showed no clear effect on Tau in both APOE4 carriers and non-carriers.

    “Serum amyloid A and tau remained unchanged for both groups.”

    Human trialin both APOE4 carriers and non-carrierslow-dose1mg/day4-week

    Rapamycin enhances neurovascular, peripheral metabolic, and immune function in cognitively normal, middle-aged APOE4 Carriers: genotype-dependent effects compared to non-carriers

    Research squarePreprint

  2. Rapamycin decreases Tau in OXYS and Wistar rats.

    “Rapamycin significantly decreased Tau and inhibited its phosphorylation in the hippocampus of OXYS and Wistar rats.”

    Animalsin OXYS and Wistar ratshippocampus0.1 or 0.5 mg/kg dailyfrom 1.5 to 3.5 months

    Rapamycin suppresses brain aging in senescence-accelerated OXYS rats

    Aging

More on Rapamycin

40-hz auditory stimulation

no changein rhesus monkeys1

1 study
  1. 40-hz auditory stimulation showed no clear effect on Tau in rhesus monkeys.

    “but no effect on Tau levels in the CSF”

    Animalscerebrospinal fluid7 consecutive daysn = 9

    Long-term effects of forty-hertz auditory stimulation as a treatment of Alzheimer's disease: Insights from an aged monkey model study

    Proceedings of the National Academy of Sciences of the United States of America

More on 40-hz auditory stimulation

Treadmill exercise

downin rats1

1 study
  1. Treadmill exercise decreases Tau in d-galactose and AlCl3-induced AD model rats.

    “The physical exercise regimen successfully ameliorated these behavioral deficits and normalized plasma tau.”

    Animalsin d-galactose and AlCl3-induced AD model ratsplasmaten weeks

    Exercise upregulates Mitsugumin 53 and ameliorates behavioral deficits and mitochondrial biogenesis in a sporadic Alzheimer's disease model in rats

    Archives of gerontology and geriatrics

More on Treadmill exercise

3xtg-ad mouse brain homogenate

upin mice1

1 study
  1. 3xtg-ad mouse brain homogenate induces Tau in 3xTg-AD mice.

    “However, the AD seeds from aged transgenic mice triggered more tau pathology.”

    Animalsin 3xTg-AD micehippocampus

    Human and Mouse Alzheimer's Seeds Differentially Affect Amyloid Deposition and Microglia-Dependent Plaque Response in Aged Mice

    Aging cell

More on 3xtg-ad mouse brain homogenate

Hormone replacement therapy

upin humans1

1 study
  1. Hormone replacement therapy is linked with higher Tau in humans.

    “In older women (aged >70 years), HT users exhibited faster regional tau accumulation relative to non-users”

    Humansbrainfemales

    Associations between hormone therapy use and tau accumulation in brain regions vulnerable to Alzheimer's disease

    Science advances

More on Hormone replacement therapy

Grape

downin humans1

1 study
  1. Grape is linked with lower Tau in humans (preclinical Alzheimer's disease with positive Aβ-PET).

    “higher intakes of fruits and grapes correlated with both lower Aβ and Tau burden”

    Humanspreclinical Alzheimer's disease with positive Aβ-PET>100 g/d

    The associations between fresh vegetable and fruit consumption and plasma and PET biomarkers in preclinical Alzheimer's disease: A cross-sectional and longitudinal study of Chinese population

    The journal of prevention of Alzheimer's disease

More on Grape

Dasatinib + quercetin

no changein humans1

1 study
  1. Dasatinib + quercetin showed no clear effect on Tau in humans.

    “The phosphorylated tau occupancy at different tau residues (pT111/T111, pT153/T153, pT181/T181, pS199/S199, pT205/T205, pS208/S208, pT217/T217, pT231/T231), as well as the levels of microtubule binding region (MTBR) for tau 212–221 (MTBR-tau212–221) and tau 243–254 (MTBR-tau243–254, an indicator of tau tangles) displayed no statistically significant changes across time points (Supplementary Figure 2 a-j and Supplementary Table 1”

    Human trialCSFthree monthsn = 5

    Evaluation of Exploratory Fluid Biomarker Results from a Phase 1 Senolytic Trial in Mild Alzheimer's Disease

    Research squarePreprint

More on Dasatinib + quercetin

Aerobic exercise

downin humans1

1 study
  1. Aerobic exercise decreases Tau in humans (Alzheimer's disease).

    “decrease in concentration of tau protein and cortisol level among others seem to be the possible mechanisms”

    ReviewAlzheimer's disease

    Understanding the mechanisms of disease modifying effects of aerobic exercise in people with Alzheimer's disease

    Ageing research reviews

More on Aerobic exercise

Modified Mediterranean-ketogenic diet

downin humans1

1 study
  1. Modified Mediterranean-ketogenic diet decreases Tau in humans.

    “The MCI group showed decreased tau after MMKD and the SMC group’s tau levels were unchanged.”

    Human trial6 weeks

    Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer's disease: a pilot study

    Neurobiology of aging

More on Modified Mediterranean-ketogenic diet

Experimental stroke

downin mice1

1 study
  1. Experimental stroke decreases Tau in mice after experimental stroke.

    “Immunoreactivity for whole tau decreased significantly in ischemic areas”

    Animalsafter experimental strokeischemic brain regions24h

    Decline of microtubule-associated protein tau after experimental stroke in differently aged wild-type and 3xTg mice with Alzheimer-like alterations

    Neuroscience

More on Experimental stroke

Effects

10

Cognitive function

downin humans3mediatesin humans1

4 studies
  1. Tau is linked with worse cognitive function in humans (preclinical Alzheimer's disease).

    “Greater MTL and NEO tau deposition were also associated with greater decline in MTB‐composite scores (Time*MTL tau: β = ‐0.30, 95%CI[‐0.48 – ‐0.13], p =.001”

    Humanspreclinical Alzheimer's diseasemedial-temporal lobe

    The remote Mobile Toolbox for capturing cognitive change in preclinical Alzheimer’s disease

    AAIC 2025 abstract

  2. Tau is linked with cognitive function in humans (cognitively unimpaired) (indirect effect β = -0.068; 95 % CI [-0.126, -0.011]).

    “Mediation analysis indicated that tau deposition significantly mediated the association between PP and cognitive decline (indirect effect β = -0.068; 95 % CI [-0.126, -0.011]).”

    Humanscognitively unimpaired240 weeksn = 1,690

    Pulse pressure as a predictor of Alzheimer's disease biomarkers and cognitive decline: The moderating role of APOE ε4

    The journal of prevention of Alzheimer's disease

  3. Tau is linked with worse cognitive function in humans.

    “FRS and tau had independent effects on cognition.”

    Humansn = 1,052

    The POINTER Imaging baseline cohort: Associations between multimodal neuroimaging biomarkers, cardiovascular health, and cognition

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  4. Tau is linked with worse cognitive function in humans (clinically normal).

    “early memory retrieval declines were associated with emerging Aβ and tau pathology”

    Humansclinically normaln = 112

    Association of Emerging β-Amyloid and Tau Pathology With Early Cognitive Changes in Clinically Normal Older Adults

    Neurology

Amygdalar pattern similarity

downin humans1

1 study
  1. Tau is linked with lower amygdalar pattern similarity in older adults without dementia below standard positivity thresholds.

    “Greater tau levels in the entorhinal cortex and amygdalae were associated with less pattern similarity in left amygdalar reactivity to negative and neutral images”

    Humansin older adults without dementia below standard positivity thresholdsentorhinal cortex

    Amygdalar Pattern Similarity to Negative and Neutral Images, Ratings of the Images, and PET-Measured Amyloid and Tau Levels in Older Adults Without Dementia

    Affective science

Driving unpredictability

upin humans1

1 study
  1. Tau is linked with higher driving unpredictability in humans (tau+ vs tau-).

    “tau+ participants exhibited slower declines in SBSOD and greater increases in driving unpredictability (i.e., higher entropy, greater percentages of chained trips/distances) across 5.6 years”

    Humanstau+ vs tau-5.6 years

    Lost before forgetting: objective driving metrics track navigation deficits tied to preclinical Alzheimer's disease

    Innovation in aging

Verbal memory

mediatesin humans1

1 study
  1. Tau is linked with verbal memory in humans (objective early cognitive impairment).

    “Tau in Braak regions I-IV mediated the relationship between acrotime and verbal memory.”

    Humansobjective early cognitive impairmentbrain

    Circadian rhythms are associated with higher amyloid-β and tau and poorer cognition in older adults

    Brain communications

Everyday functioning

downin humans1

1 study
  1. Tau is linked with worse everyday functioning in individuals with elevated amyloid.

    “Among individuals with elevated amyloid, those with the highest levels of neocortical and medial temporal tau showed the largest decline in everyday functioning”

    Humansin individuals with elevated amyloidn = 1,707

    Changes in Daily Functioning in Association With Tau and Amyloid Among Unimpaired Older Adults With and Without Elevated Amyloid

    Neurology

NIH Toolbox Cognition Battery performance

no changein humans1

1 study
  1. Tau was not clearly linked with NIH Toolbox Cognition Battery performance in humans (Hispanic participants).

    “Amyloid and tau were not associated with any test.”

    HumansHispanic participantsn = 334

    Relationship Between Alzheimer Disease Imaging Biomarkers and Performance on the NIH Toolbox Cognition Battery in Late-middle Age Hispanics

    Alzheimer disease and associated disorders

Hippocampal volume

downin humans1

1 study
  1. Tau is linked with lower hippocampal volume in humans (preclinical Alzheimer disease, elevated β-amyloid).

    “Across the A+T cortical+ and A+T MTL+ groups, increased regional tau was associated with reduced hippocampal volume and MTL thickness”

    Humanspreclinical Alzheimer disease, elevated β-amyloidbrain

    Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease

    JAMA neurology

More on Hippocampal volume

Semantic memory

downin humans1

1 study
  1. Tau impairs semantic memory in humans (without dementia) (-0.28 ([-0.52; -0.04], p = .023)).

    “weighted effect sizes were -0.28 ([-0.52; -0.04], p = .023) for semantic composite scores”

    Reviewwithout dementia

    Cross-sectional associations of tau protein biomarkers with semantic and episodic memory in older adults without dementia: A systematic review and meta-analysis

    Ageing research reviews

Episodic memory

downin humans1

1 study
  1. Tau impairs episodic memory in humans (without dementia) (-0.46 (95 % CI [-0.73; -0.20], p < .001)).

    “weighted effect sizes were -0.46 (95 % CI [-0.73; -0.20], p < .001) for episodic composite scores”

    Reviewwithout dementia

    Cross-sectional associations of tau protein biomarkers with semantic and episodic memory in older adults without dementia: A systematic review and meta-analysis

    Ageing research reviews

Regional atrophy within the medial temporal lobe

mediatesin humans1

1 study
  1. Tau is linked with regional atrophy within the medial temporal lobe in humans (cognitively normal).

    “A mediation analysis revealed that the relationship with regional atrophy was explained by MTL tau.”

    Humanscognitively normalmedial temporal lobe

    Tau and β-Amyloid Are Associated with Medial Temporal Lobe Structure, Function, and Memory Encoding in Normal Aging

    The Journal of neuroscience : the official journal of the Society for Neuroscience

Upstream

3

Female sex

upin humans1

1 study
  1. Female sex increases Tau in humans (once amyloid pathology is present).

    “women exhibit earlier or greater tau accumulation once amyloid pathology is present”

    Reviewonce amyloid pathology is presentfemales

    Considerations in Alzheimer's Disease in Women

    Current neurology and neuroscience reports

Subjective cognitive decline

no changein humans1

1 study
  1. Subjective cognitive decline was not clearly linked with Tau in humans (p > 0.38).

    “SCD was not associated with tau, p-tau, or neurofilament light (NFL) levels (p-values >0.38).”

    Humanscsf

    Cognitive status and demographics modify the association between subjective cognition and amyloid

    Annals of clinical and translational neurology

Ktrans

no changein humans1

1 study
  1. Ktrans were not clearly linked with Tau in humans (cognitively normal older adults).

    “There was not a significant relationship between Ktrans and FTP SUVR.”

    Humanscognitively normal older adultsbrainn = 31

    Associations between regional blood-brain barrier permeability, aging, and Alzheimer's disease biomarkers in cognitively normal older adults

    PloS one

More on Ktrans

Associations

47

Alzheimer's disease

upin humans4

4 studies
  1. Alzheimer's disease is associated with Tau in humans (between BB I and II) (+37.6%, p < 0.0001).

    “We observed significant LC tau accumulation between BB I and II (37.6% increase, p < 0.0001)”

    Humansbetween BB I and IIlocus coeruleusn = 11

    Locus coeruleus tau validates and informs high-resolution MRI in aging and at earliest Alzheimer's pathology stages

    Acta neuropathologica communications

  2. Tau is associated with Alzheimer's disease in humans (AD compared with PD and normal controls) (significantly higher in AD vs. PD and NC).

    “Tau, but not amyloid beta plaques, is significantly higher in AD vs. PD and NC.”

    HumansAD compared with PD and normal controlsbrainn = 15

    Neuroinflammation and Myelin Status in Alzheimer's Disease, Parkinson's Disease, and Normal Aging Brains: A Small Sample Study

    Parkinson's disease

  3. Tau raises the risk of Alzheimer's disease in humans (effect size 2.10).

    “High tau (effect size 2.10, 95% CI, I2 = 52%), and p-tau (1.95, I2 = 48%), and a decrease in Ab42 (1.75, I2 = 45%), were each found to have a consistent positive relation with an increased risk of Alzheimer's disease.”

    Review

    Early Laboratory Biomarkers as Risk Factors for Alzheimer's Disease: A Systematic Review and Meta-analysis

    AL-Kindy College Medical Journal

  4. Tau raises the risk of Alzheimer's disease in cognitively normal individuals.

    “combined amyloid and neocortical tau pathologies confer a near‐deterministic prognosis”

    Reviewin cognitively normal individuals

    Disentangling risk of progression and clinical trajectories in preclinical AD: views from the International Working Group

    AAIC 2025 abstract

More on Alzheimer's disease

Parietal periodic gamma power

upin humans1

1 study
  1. Parietal periodic gamma power is associated with Tau in humans (beta-amyloid-positive adults) (beta = +0.90, p = 0.002 in the entorhinal cortex).

    “in beta-amyloid-positive adults, higher periodic gamma was associated with higher MTL tau, most strongly in the entorhinal cortex (beta = +0.90, p = 0.002)”

    Humansbeta-amyloid-positive adultsentorhinal cortex

    High-frequency EEG activity moderates the association between amyloid burden and tau in cognitively normal adults

    medRxivPreprint

More on Parietal periodic gamma power

Inter-network hippocampal connectivity

upin humans1

1 study
  1. Tau is associated with inter-network hippocampal connectivity in humans (cognitively healthy).

    “We found that inter-network hippocampal connectivity was greater with greater amyloid and tau.”

    Humanscognitively healthyhippocampus

    Altered Resting State Hippocampal Connectivity Associated With Amyloid and Tau in Older Adults Without Dementia From a Population-Based Cohort Study

    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

More on Inter-network hippocampal connectivity

Hippocampal-retrosplenial connectivity

upin humans1

1 study
  1. Tau is associated with hippocampal-retrosplenial connectivity in humans (retrosplenial tau burden).

    “Retrosplenial tau burden was associated with higher hippocampal-retrosplenial connectivity consistent with tau spread along canonical hippocampal output pathways.”

    Humansretrosplenial tau burdenn = 75

    Mesoscale medial temporal lobe connectivity patterns relate to tau pathology and memory in older adults

    bioRxivPreprint

More on Hippocampal-retrosplenial connectivity

Valine

downin humans1

1 study
  1. Valine is associated with Tau in humans.

    “Higher levels of valine were associated with greater total white matter and posterior cingulate cortex volumes, as well as with lower levels of CSF tau proteins.”

    Humans

    Valine modulates Alzheimer's disease risk in APOE ε4 carriers: evidence from two cohorts

    Journal of advanced research

More on Valine

Age

upin humans1

1 study
  1. Age predicts Tau in Down syndrome (AUC > 0.85).

    “Age effectively differentiated amyloid positivity, tau positivity, and MCI (AUCs > 0.85)”

    Humansin Down syndromen = 461

    Age distinguished most Alzheimer’s stages in Down syndrome

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on Age

Hexadirectional modulation

downin humans1

1 study
  1. Tau is associated with hexadirectional modulation in early AD.

    “tau-linked reductions in hexadirectional modulation near the entorhinal cortex”

    Humansin early ADentorhinal cortex

    Functional neural signatures of navigation impairment in early Alzheimer’s Disease

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

More on Hexadirectional modulation

Intraindividual cognitive variability

upin humans1

1 study
  1. Intraindividual cognitive variability predicts Tau in humans (Down syndrome).

    “Greater IICV predicted incident MCI/dementia (odds ratio = 4.63 to 5.13, p < 0.05), greater amyloid burden, early tau accumulation, and higher tau across Braak stages”

    HumansDown syndromebrainn = 460

    Intraindividual cognitive variability predicts amyloid beta, tau PET, and dementia conversion in Down syndrome: a potential marker of cognitive resilience

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on Intraindividual cognitive variability

Amyloid-beta

upin humans1

1 study
  1. Tau is associated with amyloid-beta in asymptomatic carriers of ADAD mutations.

    “The Tau+ group showed significantly higher Aβ burden across all cortical and subcortical regions.”

    Humansin asymptomatic carriers of ADAD mutationsbrainn = 19

    Comparative performance of semi-quantitative methods for amyloid deposition in preclinical autosomal dominant Alzheimer's disease

    Alzheimer's research & therapy

More on Amyloid-beta

Digital maze test

upin humans1

1 study
  1. Digital maze test is associated with Tau in largely cognitively unimpaired sample (CI [0.003, 0.010]).

    “Higher pen stroke count (CI [0.003, 0.010]), and time deviating from the correct path (CI [0.0003, 0.002]) were associated with [18 F]Flortaucipir.”

    Humansin largely cognitively unimpaired samplecerebral cortexn = 221

    Digital maze test reveals cognitive performance patterns associated with amyloid-β and tau

    Neuropsychology

More on Digital maze test

All 47

Funding

179 grants since 2016

National Institute on Aging$397MNational Institute of Neurological Disorders and Stroke$11.9MAlzheimer's Association

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 47Jan 2026: 23Feb 2026: 12Mar 2026: 12Apr 2026: 10May 2026: 13Jun 2026: 17Jul 2026: 14Aug 2026: 7Sep 2026: 7Oct 2026: 7Nov 2026: 10179 papers in 12 months
Alzheimer's Research & Therapy

Spinal-fluid protein linked to Alzheimer’s progression

Higher levels of one spinal-fluid protein were linked to greater dementia risk, with a hazard ratio of 1.325, a measure of relative risk.Higher levels of one spinal-fluid protein were linked to greater dementia risk, with a hazard ratio of 1.325, a measure of relative risk.

Cohort · 706 peopleMechanisms

See all 444 papers on Tau